{
  "version": "https://jsonfeed.org/version/1.1",
  "title": "chem-bla-ics",
  "description": "Chemblaics (pronounced chem-bla-ics) is the science that uses open science and computers to solve problems in chemistry, biochemistry and related fields.",
  "home_page_url": "https://chem-bla-ics.linkedchemistry.info/",
  "feed_url": "https://chem-bla-ics.linkedchemistry.info/2006/09/13/jmol-and-cdk-add-powerful-chemical.json",
  "icon": "https://chem-bla-ics.linkedchemistry.info/assets/images/chem-bla-ics_logo.png",
  "language": "en",
  "authors": [
    {
      "name": "Egon Willighagen",
      "url": "https://orcid.org/0000-0001-7542-0286",
      "_orcid": "0000-0001-7542-0286"
    }
  ],
  "items": [

    {
      "id": "https://doi.org/10.59350/gh2mq-4qc75",
      "url": "https://chem-bla-ics.linkedchemistry.info/2006/09/13/jmol-and-cdk-add-powerful-chemical.html",
      "title": ""Jmol and the CDK add powerful chemical capabilities", says Munos in Nature Reviews Drug Discovery",
      "content_html": "<p><a href=\"http://www.nature.com/nrd/journal/vaop/ncurrent/authors/nrd2131.html\">Bernard Munos</a> at <a href=\"http://www.lilly.com/\">Eli Lilly &amp; Co.</a>\nwrote up a lengthy analysis on open source in drug discovery in <a href=\"http://www.nature.com/nrd/index.html\">Nature Reviews Drug Discovery</a>:\nCan open-source R&amp;D reinvigorate drug research? (DOI:<a href=\"https://doi.org/10.1038/nrd2131\">10.1038/nrd2131</a>). When scanning the article\nI saw this quote:</p>\n\n<p><em>Other tools such as eMolecules, Jmol or the Chemistry Development Kit are adding powerful chemical search and visualization\ncapabilities to the open-source scientist’s toolbox.</em></p>\n\n<p>Unfortunately, the paper does not point to the correct <a href=\"http://cdk.sf.net/\">CDK website</a>, but to the CUBIC backend at\n<a href=\"http://almost.cubic.uni-koeln.de/cdk\">http://almost.cubic.uni-koeln.de/cdk</a>. Moreover, I don’t think the quote does full justice to\nwhat the CDK has achieved in the past six years; I’m sure we have achieved more than a fingerprinter and some 2D and 3D rendering!</p>\n\n<h4>References</h4>\n<div class=\"csl-bib-body\">\n    <div class=\"csl-entry\">Munos, B. (2006). Can open-source R&#38;amp;D reinvigorate drug research? <i>Nature Reviews Drug Discovery</i>, <i>5</i>(9), 723–729. https://doi.org/10.1038/nrd2131 <a href=\"https://doi.org/10.1038/nrd2131\">CrossRef</a> <a href=\"https://qlever.scholia.wiki/doi/10.1038/nrd2131\">Scholia</a></div>\n  </div>",
      "summary": "Bernard Munos at Eli Lilly &amp; Co. wrote up a lengthy analysis on open source in drug discovery in Nature Reviews Drug Discovery: Can open-source R&amp;D reinvigorate drug research? (DOI:10.1038/nrd2131). When scanning the article I saw this quote:",
      
      "date_published": "2006-09-13T00:00:00+00:00",
      "date_modified": "2025-02-16T00:00:00+00:00",
      "tags": ["drugdiscovery","jmol","cdk","opensource"],
      "_references": [
        
          
          
            { "url": "https://doi.org/10.1038/nrd2131", "doi": "10.1038/nrd2131"
             }
            
          
        ],
      
      
      
      
      
      
        "authors": [ { "name": "Egon Willighagen", "url": "https://orcid.org/0000-0001-7542-0286" } ]
      
    }

  ]
}